Scolaris Content Display Scolaris Content Display

Neurokinin‐1 receptor antagonists for prevention of chemotherapy‐related nausea and vomiting in adults

Esta versión no es la más reciente

Table 1. Emetogenic potential of chemotherapy drugs (Modified from Kris 2006)

Emetogenicity

Drug

HIGH (> 90%)

Cisplatin

Dacarbazine

Mechloretamine

Streptozocin

Cyclophosphamide (> 1500 mg/m2)

Actinomycin‐D

Carmustine

MODERATE (30 to 90%)

Carboplatin

Oxaliplatin

Cyclophosphamide (<1500 mg/m2)

Lomustine (CCNU)

Daunorubicin

Doxorubicin

Epirubicin

Idarubicin

ARA‐C (Arabinoside cytosine)

Ifosfamide

Irinotecan

LOW (10 to 30%)

Paclitaxel

Docetaxel

Mitoxantrone

Topotecan

Etoposide

Pemetrexed

Methotrexate

Mitomycin

Gemcitabine

Cytarabine (< 1000 mg/m2)

Fluorouracil

Bortezomib

Cetuximab

Trastuzumab

Rituximab

Bevacizumab

Busulfan

2‐chlorodeoxyadenosine

Fludarabine

Vinblastine

Vincristine

Vinorelbine

Bleomycin

Figuras y tablas -
Table 1. Emetogenic potential of chemotherapy drugs (Modified from Kris 2006)